Cat. No. 3296
Chemical Name: 4-(4-Chlorophenyl)-3-methyl-3-buten
Biological ActivityReversible TRPA1 channel blocker (IC50 values are 3.1 and 4.5 μM at human and mouse TRPA1 respectively). Blocks cinnameldehyde-induced but not capsaicin-induced nociception and reverses mechanical hyperalgesia in vivo. Also blocks TRPA1 pore dilation (IC50 = 10.3 μM for the inhibition of Yo-Pro uptake).
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Datasheet
References are publications that support the products' biological activity.
Chen et al (2009) Pore dilation occurs in TRPA1 but not in TRPM8 channels. Mol.Pain 5 3. PMID: 19159452.
Taylor-Clark et al (2009) Nitrooleic acid, an endogenous product of nitrative stress, activates nociceptive sensory nerves via the direct activation of TRPA1. Mol.Pharmacol. 75 820. PMID: 19171673.
Petrus et al (2007) A role of TRPA1 in mechanical hyperalgesia is revealed by pharmacological inhibition. Mol.Pain 3 40. PMID: 18086313.
If you know of a relevant reference for AP 18 please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses AP 18 from Tocris? If so please let us know.
View Related Products by Product Action
Keywords: AP 18, supplier, Reversible, TRPA1, channel, blockers, Channels, Transient, Receptor, Potential, AP18, Tocris Bioscience, TRPA1 Blocker products